<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">smjournal</journal-id><journal-title-group><journal-title xml:lang="ru">Спортивная медицина: наука и практика</journal-title><trans-title-group xml:lang="en"><trans-title>Sports medicine: research and practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2223-2524</issn><issn pub-type="epub">2587-9014</issn><publisher><publisher-name>NEICON</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17238/ISSN2223-2524.2019.4.33</article-id><article-id custom-type="elpub" pub-id-type="custom">smjournal-179</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>БИОМЕДИЦИНСКИЕ ТЕХНОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BIOMEDICAL TECHNOLOGIES</subject></subj-group></article-categories><title-group><article-title>Современные аспекты применения плазмы, обогащенной растворимыми факторами тромбоцитов, в лечении травм и заболеваний опорно-двигательного аппарата</article-title><trans-title-group xml:lang="en"><trans-title>Modern aspects of the use of plasma enriched in soluble platelet factors in the treatment of injuries and diseases of the musculoskeletal system</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7705-9383</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Потапнев</surname><given-names>М. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Potapnev</surname><given-names>M. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Потапнев Михаил Петрович, заведующий отделом клеточных биотехнологий, проф., д.м.н.   </p><p>Минск</p><p>+375-29-638-02-71</p></bio><bio xml:lang="en"><p>Michael P. Potapnev, M.D., D.Sc. (Medicine), Prof., Head of the Department of Cellular BioTechnologies </p><p>Minsk</p><p>+375-29-638-02-71 </p></bio><email xlink:type="simple">mpotapnev@yandex.by</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9930-253X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Загородный</surname><given-names>Г. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zagorodny</surname><given-names>G. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Загородный Геннадий Михайлович, заместитель директора по клинике, доцент, к.м.н.  </p><p>Минск</p></bio><bio xml:lang="en"><p>Gennady M. Zagorodny, M.D., Ph.D. (Medicine), Deputy Director for Clinic </p><p>Minsk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6813-4465</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кривенко</surname><given-names>С. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Krivenko</surname><given-names>S. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кривенко Светлана Ивановна, заместитель директора по научной работе, доцент, д.м.н.  </p><p>Минск</p></bio><bio xml:lang="en"><p>Svetlana I. Krivenko, M.D., D.Sc. (Medicine), Deputy Director for Research </p><p>Minsk</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7849-6497</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Богдан</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Bogdan</surname><given-names>V. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Богдан Василий Генрихович, начальник военно-медицинского факультета, проф., д.м.н.  </p><p>Минск</p></bio><bio xml:lang="en"><p>Vasiliy G. Bogdan, M.D., D.Sc. (Medicine), Prof., Head of the Faculty of Military Medicine </p><p>Minsk</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7691-5464</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Свирский</surname><given-names>А. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Svirsky</surname><given-names>A. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Свирский Антон Олегович, научный сотрудник </p><p>Минск</p></bio><bio xml:lang="en"><p>Anton O. Svirsky, Scientist </p><p>Minsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0814-8707</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ясюкевич</surname><given-names>А. C.</given-names></name><name name-style="western" xml:lang="en"><surname>Yasyukevich</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ясюкевич Андрей Сергеевич, научный сотрудник </p><p>Минск</p></bio><bio xml:lang="en"><p>Andrei S. Yasyukevich, Scientist </p><p>Minsk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2257-6452</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Асаевич</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Asaevich</surname><given-names>V. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Асаевич Вадим Игоревич, младший научный сотрудник </p><p>Минск</p></bio><bio xml:lang="en"><p>Vadim I. Asaevich, Junior Researcher </p><p>Minsk</p></bio><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6076-3761</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Букач</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bukach</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Букач Дмитрий Вячеславович, научный сотрудник  </p><p>Минск</p></bio><bio xml:lang="en"><p>Dmitry V. Bukach, M.D., Scientist </p><p>Minsk</p></bio><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1002-4132</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Эйсмонт</surname><given-names>О. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Eismont</surname><given-names>O. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Эйсмонт Олег Леонидович, заместитель директора по научной работе, доцент, д.м.н.  </p><p>Минск</p></bio><bio xml:lang="en"><p>Oleg L. Eismont, M.D., D.Sc. (Medicine), Deputy Director for Research </p><p>Minsk</p></bio><xref ref-type="aff" rid="aff-6"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Республиканский научно-практический центр трансфузиологии и медицинских биотехнологий</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Republican Scientific and Practical Center of Transfusiology and Medical Biotechnologies</institution><country>Belarus</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Республиканский научно-практический центр спорта</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Republican Scientific and Practical Center of sports</institution><country>Belarus</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Минский научно-практический центр хирургии, трансплантологии и гематологии</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Minsk Scientific and Practical Center for Surgery, Transplantation and Hematology</institution><country>Belarus</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Белорусский государственный медицинский университет</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Belarusian State Medical University</institution><country>Belarus</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Республиканский научно-практический центр трансфузиологии и медицинских биотехнологий</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Republican Scientific and Practical Center of sports</institution><country>Belarus</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>Республиканский научно-практический центр травматологии и ортопедии</institution><country>Беларусь</country></aff><aff xml:lang="en"><institution>Republican Scientific and Practical Center of Traumatology and Orthopedics</institution><country>Belarus</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>28</day><month>08</month><year>2020</year></pub-date><volume>9</volume><issue>4</issue><fpage>33</fpage><lpage>45</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Потапнев М.П., Загородный Г.М., Кривенко С.И., Богдан В.Г., Свирский А.О., Ясюкевич А.C., Асаевич В.И., Букач Д.В., Эйсмонт О.Л., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Потапнев М.П., Загородный Г.М., Кривенко С.И., Богдан В.Г., Свирский А.О., Ясюкевич А.C., Асаевич В.И., Букач Д.В., Эйсмонт О.Л.</copyright-holder><copyright-holder xml:lang="en">Potapnev M.P., Zagorodny G.M., Krivenko S.I., Bogdan V.G., Svirsky A.O., Yasyukevich A.S., Asaevich V.I., Bukach D.V., Eismont O.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.smjournal.ru/jour/article/view/179">https://www.smjournal.ru/jour/article/view/179</self-uri><abstract><p>В обзоре литературы представлены данные о новом направлении в лечении спортивных травма и заболеваний опорно-двигательного аппарата – использовании собственной плазмы, обогащенной тромбоцитами плазмы, обогащенной растворимыми факторами тромбоцитов (PRP/ПОРФТ). PRP/ПОРФТ оказывает противовоспалительное, обезболивающее, антикатаболическое и регенеративное действие при локальном введении в область поражения. Рассмотрены вопросы технологий приготовления и клинического применения PRP/ПОРФТ. Дан анализ результатов клинических наблюдений по её использованию в спортивной медицине и повреждениях опорно-двигательного аппарата. Показана клиническая эффективность 2-3 кратного введения PRP/ПОРФТ в область травмы или повреждения мышц, связок, суставов. Наиболее эффективно было использование PRP/ПОРФТ при лечении эпикондилита локтевого сустава и остеоартрита. Не выявлено достоверной эффективности применения PRP/ПОРФТ при повреждениях ахиллова сухожилия. Отмечен наибольший клинический эффект применения PRP/ПОРФТ при травмах и заболеваниях опорно-двигательного аппарата на начальных этапах лечения, а также при проведении реабилитационных курсов терапии.</p></abstract><trans-abstract xml:lang="en"><p>The review of literature presents the new direction in the treatment of sports injuries and diseases of the musculoskeletal system – using of autologous platelet-rich plasma/plasma enriched in soluble platelet factors (PRP/PORFT). PRP/PORFT reveals anti-inflammatory, analgesic, anticatabolic and regenerative effects after local injection to affected area. Technology of preparation and clinical application of PRP/PORFT were under consideration. There were described the results of clinical studies on PRP/PORFT application in sports medicine and damage of musculoskeletal system. It was shown the clinical efficacy of 2-3 injections of PRP/PORFT into the area of muscle, ligaments, joints injury. Most effective use of PRP/PORFT was shown for therapy of lateral epicondylitis and osteoarthritis. There were no yet evidences for its efficacy in therapy of patients with damaged Achilles tendon. The best clinical effects of PRP/PORFT use was demonstrated in patients with trauma and damage of musculoskeletal system at the initial stages of treatment, and also as a part of rehabilitation courses.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>плазма</kwd><kwd>обогащенная тромбоцитами/плазма</kwd><kwd>обогащенная растворимыми факторами тромбоцитов</kwd><kwd>спортивные травмы</kwd><kwd>заболевания</kwd><kwd>опорно-двигательный аппарат</kwd></kwd-group><kwd-group xml:lang="en"><kwd>platelet-rich plasma/plasma enriched in soluble platelet factors</kwd><kwd>sports injury</kwd><kwd>disease</kwd><kwd>musculoskeletal system</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена в рамках выполнения НИОК(Т)Р (гранты Министерства здравоохранения Республики Беларусь № 20191216 и 20192193)</funding-statement><funding-statement xml:lang="en">This study was conducted with financial support of Ministry of Health the Republic of Belarus (grants # 20191216 and # 20192193).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Andia I, Maffulli N. How far have biological therapies come in regenerative sport medicine? // Expert Opinion on Biological therapy. 2018. Vol.18. №.7. P. 785-793.</mixed-citation><mixed-citation xml:lang="en">Andia I, Maffulli N. How far have biological therapies come in regenerative sport medicine? Expert Opinion on Biological therapy. 2018;18(7):785-793.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Yang A, Hunter CW, McJunkin TL. PRP therapies (tendons, joints, spine) // Springer Nature Switzerland AG. 2019. P. 749-756.</mixed-citation><mixed-citation xml:lang="en">Yang A, Hunter CW, McJunkin TL. PRP therapies (tendons, joints, spine). Deer’s treatment of pain. Springer Nature Switzerland AG. 2019;91:749-756.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu Y, Yuan M, Meng HY, Wang AY, Guo QY, Wang Y, Peng J. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review // Osteoarthritis and cartilage. 2013. Vol.21, P. 1627-1637.</mixed-citation><mixed-citation xml:lang="en">Zhu Y, Yuan M, Meng HY, Wang AY, Guo QY, Wang Y, Peng J. Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis and cartilage. 2013;21:1627-1637.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Milants C, Bruyere O, Kaux J-F. Responders to platelet-rich plasma in osteoarthritis: a technical analysis // BioMed Research International. 2017. Vol.1. P. 11.</mixed-citation><mixed-citation xml:lang="en">Milants C, Bruyere O, Kaux J-F. Responders to platelet-rich plasma in osteoargtritis: a technical analysis. BioMed Research International. 2017;(1):1-11. DOI:10.1155/2017/7538604</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cook CS, Smith PA. Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee // Current Reviews in Musculosceletal Medicine. 2018. Vol.11. P. 583-592.</mixed-citation><mixed-citation xml:lang="en">Cook CS, Smith PA. Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee. Current Reviews in Musculosceletal Medicine. 2018;11: 583-592.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Rossi LA, Romoli ARM, Altieri BAB, Flor JAB., Scordo WE, Elizondo CM. Does Platelet-rich plasma decrease time to return to sports in acute muscle tear? A randomized controlled trial // Knee Surgery, Sports Traumatology, Arthroscopy. 2017. Vol.25. P. 3319-3325.</mixed-citation><mixed-citation xml:lang="en">Rossi LA, Romoli ARM, Altieri BAB, Flor JAB, Scordo WE, Elizondo CM. Does Platelet-rich plasma decrease time to return to sports in acute muscle tear? A randomized controlled trial. Knee Surgery, Sports Traumatology, Arthroscopy. 2017;25:3319-3325.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Setayesh K, Villarreal A, Gottschalk A, Tokish JM, Choate WS. Treatment of muscle injuries with platelet-rich plasma: a review of the literature // Current Reviews in Musculosceletal Medicine. 2018. Vol.11. P. 636-642.</mixed-citation><mixed-citation xml:lang="en">Setayesh K, Villarreal A, Gottschalk A, Tokish JM, Choate WS. Treatment of muscle injuries with platelet-rich plasma: a review of the literature. Current Reviews in Musculosceletal Medicine. 2018;11:636-642.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Bisciotti GN, Volpi P, Amato M, Alberti G, Allegra F, Aprato A, Aptina M, Auci A, Bait C, Bastieri GM, Balzarini L, Belli A, Bellini G, Bettinsoli P, Bisciotti A, Bisciotti A, Bona S, Brambilla L, Bresciani M. Italian consensus conference on guidelines for conservative treatment on lower limb muscle injuries in athlete // BMJ Open Sport &amp; Exercise Medicine. 2018. Vol.4. P.e000323.</mixed-citation><mixed-citation xml:lang="en">Bisciotti GN, Volpi P, Amato M, Alberti G, Allegra F, Aprato A, Aptina M, Auci A, Bait C, Bastieri GM, Balzarini L, Belli A, Bellini G, Bettinsoli P, Bisciotti A, Bisciotti A, Bona S, Brambilla L, Bresciani M. Italian consensus conference on guidelines for conservative treatment on lower limb muscle injuries in athlete. BMJ Open Sport &amp; Exercise Medicine. 2018;4:e000323.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Загородный Г.М., Муха П.Г., Ясюкевич А.С., Гулевич Н.П. Отечественный и зарубежный опыт применения PRP-терапии в медицине и спортивной практике // Прикладная спортивная наука. 2017. №1(5). С. 83-91.</mixed-citation><mixed-citation xml:lang="en">Zagorodny GM, Mucha PG, Yasyukevich AS, Gulevich NP. Otechestvennyy i zarubezhnyy opyt primeneniya PRP-terapii v meditsine i sportivnoy praktike (obzor literatury). Prikladnaya sportivnaya nauka. 2017;1(5):83-91. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Cugat R, Cusco X, Srijas R, Barastegui D, Alvarez-Diaz P, Alentorn-Geli E, Rius M, Steinbacher G, Sala E, Boffa JJ, Grossi S, Garcia-Balletbo M, Tizol S, Laiz P. PRGF on sport-related ligament injuries. Platelet rich plasma in orthopaedics and sports medicine. Springer International Publishing AG. 2018. Ch.10. P. 175-188.</mixed-citation><mixed-citation xml:lang="en">Cugat R, Cusco X, Srijas R, Barastegui D, Alvarez-Diaz P, Alentorn-Geli E, Rius M, Steinbacher G, Sala E, Boffa JJ, Grossi S, Garcia-Balletbo M, Tizol S, Laiz P. PRGF on sport-related ligament injuries. Platelet rich plasma in orthopaedics and sports medicine. Springer International Publishing AG, part of Springer Nature. 2018;10:175-188.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ачкасов Е.Е., Литвиненко А.С., Куршев В.В. Ударноволновая терапия при заболеваниях и травмах опорно-двигательного аппарата, обусловленных занятием спортом // Вестник восстановительной медицины. 2015. №1 (65). С. 42-50.</mixed-citation><mixed-citation xml:lang="en">Achkasov EE, Litvinenko AS, Kurshev VV. Shockwave therapy in diseases and injuries of the musculoskeletal system due sports. Bulletin of rehabilitation medicine. 2015;1(65):42-50. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Цыкунов М.Б. Эффективность тренировки с биологической обратной связью при повреждениях капсульно-связочных структур коленного сустава. // Вестник восстановительной медицины. 2018. №4 (86). С. 29-33.</mixed-citation><mixed-citation xml:lang="en">Tsykunov MB. The effectiveness of training with biological feedback for damage capsular-ligament structures of the knee joint. Bulletin of rehabilitation medicine. 2018;4(86):29-33. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Piuzzi NS, Dominici M, Long M, Pascual-Garrido C, Rodeo S, Huard J, Guicheux J, McFarland R, Goodrich LR, Maddens S, Robey PG, Bauer TW, Barrett J, Barry F, Karli D, Chu CR, Weiss DJ, Martin I, Jorgensen C, Muschler GF. Proceedings of the signature series symposium «cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies – promise, facts and fantasy», international society for cellular therapies, Montreal Canada, May 2, 2018 // Cytotherapy. 2018. Vol.20. P. 1381-1400.</mixed-citation><mixed-citation xml:lang="en">Piuzzi NS, Dominici M, Long M, Pascual-Garrido C, Rodeo S, Huard J, Guicheux J, McFarland R, Goodrich LR, Maddens S, Robey PG, Bauer TW, Barrett J, Barry F, Karli D, Chu CR, Weiss DJ, Martin I, Jorgensen C, Muschler GF. Proceedings of the signature series symposium «cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies – promise, facts and fantasy», international society for cellular therapies, Montreal Canada, May 2, 2018. Cytotherapy. 2018;20:1381-1400.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sanchez M, Azofra J, Anitua E, Andia I, Padilla S, Santisteban J, Mujika I. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report // Medicine &amp; Science in Sports &amp; Exercise. 2003. Vol.35. P. 1648-1652.</mixed-citation><mixed-citation xml:lang="en">Sanchez M, Azofra J, Anitua E, Andia I, Padilla S, Santisteban J, Mujika I. Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Medicine &amp; Science in Sports &amp; Exercise. 2003;35:1648-1652.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Scully D, Matsakas A. Current insight into the potential misuse of platelet-based applications for doping in sports // International Journal of Sports Medicine. 2019. Vol.40. P. 427-433.</mixed-citation><mixed-citation xml:lang="en">Scully D, Matsakas A. Current insight into the potential misuse of platelet-based applications for doping in sports. International Journal of Sports Medicine. 2019;40:427-433.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Andia I, Abate M. Platelet-rich plasma: underlying biology and clinical correlates // Regenerative Medicine. 2013. Vol.8, №5. P. 645-658.</mixed-citation><mixed-citation xml:lang="en">Andia I, Abate M. Platelet-rich plasma: underlying biology and clinical correlates. Regenerative Medicine. 2013;8(5):645-658.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Потапнев М.П., Арабей А.А., Кондратенко Г.Г., Троянов А.А., Космачева С.М., Игнатенко С.И., Кохно Е.А., Данилкович Н.Н., Кривенко С.И., Назарова Е.А., Левандовская О.В., Копецкий И.С., Логинов В.В. Растворимые факторы тромбоцитов и регенеративная медицина // Здравоохранение. 2014. №9. C. 32-40.</mixed-citation><mixed-citation xml:lang="en">Potapnev MP, Arabey AA, Kondratenko GG, Troyanov AA, Kosmacheva SM, Ihnatsenko SI, Kakhno AA, Danilkovich NN, Krivenko SI, Nazarova EA, Levandovskaya OV, Kopetski IS, Loginov VV. Soluble preparations of platelet growth factors and their medical implementation Zdravookhraneniye (Minsk) (Healthcare). 2014;9:32-40. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Renn T-Y, Kao Y-H, Wang C-C, Burnouf T. Antiinflammatory effects of platelet biomaterials in a macrophage cellular model // Vox Sanguinus. 2015. Vol.109, №2. P. 138-147.</mixed-citation><mixed-citation xml:lang="en">Renn TY, Kao YH, Wang CC, Burnouf T. Anti-inflammatory effects of platelet biomaterials in a macrophage cellular model. Vox Sanguinus. 2015;109(2):138-147.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Navani A, Li G, Chrystal J. Platelet rich plasma in musculoskeletal pathology: a necessary rescue or a lost cause? // Pain Physician. 2017. Vol.20. P. e345-e356.</mixed-citation><mixed-citation xml:lang="en">Navani A, Li G, Chrystal J. Platelet rich plasma in musculoskeletal pathology: a necessary rescue or a lost cause? Pain Physician. 2017;20:345-356.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Гаин Ю.М., Герасименко М.А., Шахрай С.В., Хрыщанович В.Я., Богдан В.Г., Бордаков П.В., Гаин М.Ю. Возможности и перспективы использования обогащенной тромбоцитами плазмы в хирургии и медицине // Инновационные технологии в медицине. 2017. Т.5, №3. С. 104-124.</mixed-citation><mixed-citation xml:lang="en">Gain YM, Gerasimenko MA, Shakhray SV, Hrischanovich VY, Bogdan VG, Bordakov PV, Gain MY. Possibilities and prospects of platelet rich plasma in surgery and medicine. Innovative technologies in medicine. 2017;5(3):104-124. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Lana JF, Huber SC, Purita J, Tambeli CH, Santos GS, Paulus C, Annichino-Bizzachi JM. Leukocyte-rich PRP versus Leukocyte-poor PRP- The role of monocyte / macrophage function in the healing cascade // Journal of Clinical Orthopaedics and Trauma. 2019. 13;10(1):7-12. DOI:10.1016/jjcot.2019.05.008</mixed-citation><mixed-citation xml:lang="en">Lana JF, Huber SC, Purita J, Tambeli CH, Santos GS, Paulus C, Annichino-Bizzachi JM. Leukocyte-rich PRP versus Leukocyte-poor PRP - The role of monocyte/macrophage function in the healing cascade. Journal of Clinical Orthopaedics and Trauma. 2013;13;10(1):S7-S12. DOI:10.1016/jjcot.2019.05.008</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Chelini F, Tani A, Zecchi-Orlandini S, Sassoli C. Influence of platelet-rich and platelet-poor plasma on endogenous mechanisms of skeletal muscle repair/regeneration // International Journal of Molecular Science. 2019. Vol.20. P.683.</mixed-citation><mixed-citation xml:lang="en">Chelini F, Tani A, Zecchi-Orlandini S, Sassoli C. Influence of platelet-rich and platelet-poor plasma on endogenous mechanisms of skeletal muscle repair/regeneration. International Journal of Molecular Science. 2019;20:683.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Khoshbin A, Leroux T, Wasserstein D, Mark P, Theodoropoulos J, Ogilvie-Harris D, Gandhi R, Takhar K, Kin B, Lum G, Chahal J. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systemic review with quantitative synthesis // Arthroscopy. The Journal of Arthroscopic and Related Surgery. 2013. Vol.29, №12. P. 2037-2048.</mixed-citation><mixed-citation xml:lang="en">Khoshbin A, Leroux T, Wasserstein D, Mark P, Theodoropoulos J, Ogilvie-Harris D, Gandhi R, Takhar K, Kin B, Lum G, Chahal J. The efficacy of platelet-rich plasma in the treatment of symptomatic knee osteoarthritis: a systemic review with quantitative synthesis. Arthroscopy. The Journal of Arthroscopic and Related Surgery. 2013;29(12):2037-2048.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">O’Connel B, Wragg NM, Wilson SL. The use of PRP injections in the management of knee osteoarthritis // Cell and Tissue Research. 2019. Vol.376. P. 143-152.</mixed-citation><mixed-citation xml:lang="en">O’Connel B, Wragg NM, Wilson SL. The use of PRP injections in the management of knee osteoarthritis. Cell and Tissue Research. 2019;376:143-152.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Saclier M, Cuvellier S, Magnan M, Mounier R, Chazaud B. Monocyte / macrophage interactions with myogenic precursor cells during skeletal muscle regeneration // FEBS Journal. 2013. Vol.280. P. 4118-4130.</mixed-citation><mixed-citation xml:lang="en">Saclier M, Cuvellier S, Magnan M, Mounier R, Chazaud B. Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration. FEBS Journal. 2013;280: 4118-4130.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Stratos I, Mittlmeier T. Muscle, ligament and tendon regeneration. In book: Regenerative Medicine – from protocol to patient. Springer Int. Publ. Switzerland. 2016. Ch. 11. P. 349-366. DOI: 10.1007/978-3-319-28386-9_11</mixed-citation><mixed-citation xml:lang="en">Stratos I, Mittlmeier T. Muscle, ligament and tendon regeneration. In book: Regenerative Medicine – from protocol to patient. Springer Int. Publ. Switzerland. 2016;11:349-366. DOI: 10.1007/978-3-319-28386-9_11</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Andia I, Latorre PM, Gomez MC, Burgos-Alonso N, Abate M, Maffulli N. Platelet-rich plasma in the conservative treatment of painful tendinopathy: a systemic review and metaanalysis of controlled studies // British Medical Bulletin. 2014. Vol.110. P. 99-115.</mixed-citation><mixed-citation xml:lang="en">Andia I, Latorre PM, Gomez MC, Burgos-Alonso N, Abate M, Maffulli N. Platelet-rich plasma in the conservative treatment of painful tendinopathy: a systemic review and meta-analysis of controlled studies. British Medical Bulletin. 2014;110:99-115.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation of osteoarthritis // Nature Reviews. Rheumatology. 2013. Vol.9. P. 721-730.</mixed-citation><mixed-citation xml:lang="en">Andia I, Maffulli N. Platelet-rich plasma for managing pain and inflammation of osteoarthritis. Nature Reviews. Rheumatology. 2013;9:721-730.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Потапнев М.П., Кривенко С.И., Богдан В.Г., Космачева С.М., Шляга О.Л., Карпенко Ф.Н. Плазма крови, обогащенная растворимыми факторами тромбоцитов: получение, стандартизация, медицинское применение // Здравоохранение. 2018. №10 (859). С.38-44.</mixed-citation><mixed-citation xml:lang="en">Potapnev MP, Krivenko SI, Bogdan VG, Kosmacheva SM, Shlyaga OL, Karpenko FN. Platelet-rich derived plasma: manufacture and medical application. Zdravookhraneniye (Minsk) (Healthcare). 2018;10(859):38-44. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Gholami M, Ravaghi H, Salehi M, Yekta AA, Doaee S, Jaafaripooyan E. A systemic review and meta-analysis of the application of platelet-rich plasma in sports medicine // Electronic Physician. 2016. Vol.8, №5. P. 2325-2332.</mixed-citation><mixed-citation xml:lang="en">Gholami M, Ravaghi H, Salehi M, Yekta AA, Doaee S, Jaafaripooyan E. A systemic review and meta-analysis of the application of platelet-rich plasma in sports medicine. Electronic Physician. 2016;8(5):2325-2332.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Piccin A, Di Pierro A.M, Canzian L, Primerano M, Corvetta D, Negri G, Mazzoleni G, Gastl G, Steurer M, Gentilini I, Eisendle K, Fontanella F. Platelet gel: a new therapeutic tool with great potential // Blood Transfusion, 2017. Vol.15. P. 33-340.</mixed-citation><mixed-citation xml:lang="en">Piccin A, Di Pierro AM, Canzian L, Primerano M, Corvetta D, Negri G, Mazzoleni G, Gastl G, Steurer M, Gentilini I, Eisendle K, Fontanella F. Platelet gel: a new therapeutic tool with great potential. Blood Transfusion. 2017;15:333-340.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Cohn CS, Lockhart E, McCullough JJ. The use of autologous platelet-rich plasma in the orthopedic setting // Transfusion. 2015. Vol.55. P. 1812-1820.</mixed-citation><mixed-citation xml:lang="en">Cohn CS, Lockhart E, McCullough JJ. The use of autologous platelet-rich plasma in the orthopedic setting. Transfusion. 2015;55:1812-1820.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Hamid MSA, Ali MRM, Yusof A, George J, Lee LPC. Platelet-rich plasma injections for the treatment of hamstring injuries: a randomized controlled trial // The American Journal of Sports Medicine. 2014. Vol.42, №10. P. 2410-2418.</mixed-citation><mixed-citation xml:lang="en">Hamid MSA, Ali MRM, Yusof A, George J, Lee LPC. Platelet-rich plasma injections for the treatment of hamstring injuries: a randomized controlled trial. The American Journal of Sports Medicine. 2014;42(10):2410-2418.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Scott A, LaPrade RF, Harmon K.G, Filardo G, Kon E, Della Villa S, Bahr R, Moksnes H, Torgalsen T, Lee J, Dragoo JL, Engebretsen L. Platelet-rich plasma for patellar tendinopathy. A randomized controlled trial of leukocyte-rich PRP or leukocyte-poor PRP versus saline // The American Journal of Sports Medicine. 2019. Vol.47, №7. P.1654-1661.</mixed-citation><mixed-citation xml:lang="en">Scott A, La Prade RF, Harmon KG, Filardo G, Kon E, Della Villa S, Bahr R, Moksnes H, Torgalsen T, Lee J, Dragoo JL, Engebretsen L. Platelet-rich plasma for patellar tendinopathy. A randomized controlled trial of leukocyte-rich PRP or leukocyte-poor PRP versus saline. The American Journal of Sports Medicine. 2019;47(7):1654-1661.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Gato-Calvo L, Magalhaes J, Ruiz-Romero C, Blanco FJ, Burguera EF. Platelet-rich plasma: review of current evidence // Therapeutic Advances in Chronic Disease. 2019. Vol.10. P. 1-18.</mixed-citation><mixed-citation xml:lang="en">Gato-Calvo L, Magalhaes J, Ruiz-Romero C, Blanco FJ, Burguera EF. Platelet-rich plasma: review of current evidence. Therapeutic Advances in Chronic Disease. 2019;10:1-18.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Strunk D, Lozano M, Marks DC, Loh YS, Gstraunthaler G, Schennach H, Rohde E, Laner-Plamberger S, Oller M, Nystedt J, Lotfi R, Rojewski M, Schrezenmeier H, Bieback K, Schafer R, Bakchout T, Waidmann M, Jonsdottir-Buch SM, Montazeri H, Sigurjonsson OE, Iudicone P, Fioravanti D, Pierelli L, Introna M, Capelli C, Falanga A, Takanishi M, Lopez-Villar O, Burnouf T, Reems JA, Pierce J, Prestal AM, Schallmoser K. International forum on GMP-grade human platelet lysate for cell propagation: summary // Vox Sanguinus. 2018. Vol.113. P. 80-87.</mixed-citation><mixed-citation xml:lang="en">Strunk D, Lozano M, Marks DC, Loh YS, Gstraunthaler G, Schennach H, Rohde E, Laner-Plamberger S, Oller M, Nystedt J, Lotfi R, Rojewski M, Schrezenmeier H, Bieback K, Schafer R, Bakchout T, Waidmann M, Jonsdottir-Buch SM, Montazeri H, Sigurjonsson OE, Iudicone P, Fioravanti D, Pierelli L, Introna M, Capelli C, Falanga A, Takanishi M, Lopez-Villar O, Burnouf T, Reems JA, Pierce J, Prestal AM, Schallmoser K. International forum on GMP-grade human platelet lysate for cell propagation: summary. Vox Sanguinus. 2018;113:80-87.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Bubnov R, Yevseenko V, Semeniv I. Ultrasound guided injections of platelet rich plasma for muscle injury in professional athletes. Comparative study // Medical Ultrasonography. 2013. Vol.15, №2. P. 101-105.</mixed-citation><mixed-citation xml:lang="en">Bubnov R, Yevseenko V, Semeniv I. Ultrasound guided injections of platelet rich plasma for muscle injury in professional athletes. Comparative study. Medical Ultrasonography. 2013;15(2): 101-105.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Medvedev AV, Kholodkova OL, Borysova OV, Bahchevan OL. The effectiveness of platelet-rich plasma (PRP) administration in professional football players’ muscle injuries // Галицький лiкарский вiсник. 2015. Т.22 (3, частина 2). С. 29-33. http://nbuv.gov.ua/UJRN/glv_2015_22_3%282%29__12</mixed-citation><mixed-citation xml:lang="en">Medvedev AV, Kholodkova OL, Borysova OV, Bahchevan OL. The effectiveness of platelet-rich plasma (PRP) administration in professional football players’ muscle injuries. Galits'kiy likarskiy visnik. 2015;22(3):29-33. http://nbuv.gov.ua/UJRN/glv_2015_22_3%282%29__12 Ukrainian</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Bernuzzi G, Petraglia F, Pedrini M.F, De Filippo M, Pogliacomi F, Verdano MA, Costantino C. Use of plateletrich plasma in the care of sports injuries: our experience with ultrasound-guided injection // Blood Transfusion. 2014. Vol.12 (suppl.1). P. 229-234.</mixed-citation><mixed-citation xml:lang="en">Bernuzzi G, Petraglia F, Pedrini MF, De Filippo M, Pogliacomi F, Verdano MA, Costantino C. Use of platelet-rich plasma in the care of sports injuries: our experience with ultrasoundguided injection. Blood Transfusion. 2014;12(1):229-234.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Borrione P, Fossati C, Pereira MT, Giannini S, Davico M, Minganti C, Pigozzi F. The use of platelet-rich plasma (PRP) in the treatment of gastrocnemius strains: a retrospective observational study // Platelets. 2018. Vol.29, №6. P. 5 96-601.</mixed-citation><mixed-citation xml:lang="en">Borrione P, Fossati C, Pereira MT, Giannini S, Davico M, Minganti C, Pigozzi F. The use of platelet-rich plasma (PRP) in the treatment of gastrocnemius strains: a retrospective observational study. Platelets. 2018;29(6):596-601.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Aprili G, Gandini G, Guaschino R, Mazzucco L, Salvaneschi L, Vaglio S. SIMTI recommendations on blood components for non-transfusional use // Blood Transfusion. 2013. Vol.11, №4. P. 611-622.</mixed-citation><mixed-citation xml:lang="en">Aprili G, Gandini G, Guaschino R, Mazzucco L, Salvaneschi L, Vaglio S.SIMTI recommendations on blood components for non-transfusional use. Blood Transfusion. 2013;11(4):611-622.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma // The American Journal of Sports Medicine. 2006. Vol.34, №11. P. 1774-1778.</mixed-citation><mixed-citation xml:lang="en">Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. The American Journal of Sports Medicine. 2006;34(11):1774-1778.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis. A double-blind randomized controlled trial with 2-year follow-up // The American Journal of Sports Medicine. 2011. Vol.39, №6. P. 1200-1208.</mixed-citation><mixed-citation xml:lang="en">Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis. A double-blind randomized controlled trial with 2-year follow-up. The American Journal of Sports Medicine. 2011;39(6):1200-1208.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Omar AS, Ibrahim ME, Ahmed AS, Said M. Local injection of autologous platelet rich plasma and corticosteroid in treatment of lateral epicondylitis and plantar fasciitis: randomized clinical trial // The Egyptian Rheumatologist. 2012. Vol.34, №2. P. 43-49.</mixed-citation><mixed-citation xml:lang="en">Omar AS, Ibrahim ME, Ahmed AS, Said M. Local injection of autologous platelet rich plasma and corticosteroid in treatment of lateral epicondylitis and plantar fasciitis: randomized clinical trial. The Egyptian Rheumatologist. 2012;34(2):43-49.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Abate M, Di Carlo L, Salini V. Platelet-rich plasma diffusion in Achilles tendon: relationship with therapeutic outcomes // Medical Principles and Practice. 2019. Vol.28. P. 367-372.</mixed-citation><mixed-citation xml:lang="en">Abate M, Di Carlo L, Salini V. Platelet-rich plasma diffusion in Achilles tendon: relationship with therapeutic outcomes. Medical Principles and Practice. 2019;28:367-372.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">McCrum C.L, Costello J, Onishi K, Stewart C, Vyas D. Return to play after PRP and rehabilitation of 3 elite ice hockey players with ulnar collateral ligament injuries of the elbow // The Orthopaedic Journal of Sports Medicine. 2018. Vol.6, №8. 2325967118790760</mixed-citation><mixed-citation xml:lang="en">McCrum CL, Costello J, Onishi K, Stewart C, Vyas D. Return to play after PRP and rehabilitation of 3 elite ice hockey players with ulnar collateral ligament injuries of the elbow. The Orthopaedic Journal of Sports Medicine. 2018;6(8):2325967118790760.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Sanli I, Morgan B, van Tilborg F, Funk L, Gosens T. Single injection of platelet-rich plasma (PRP) for the treatment of refractory distal biceps tendonitis: long-term results of a prospective multicenter cohort study // Knee Surgery, Sports Traumatology, Arthroscopy. 2016. Vol.24, №7. P. 2308-2312.</mixed-citation><mixed-citation xml:lang="en">Sanli I, Morgan B, van Tilborg F, Funk L, Gosens T. Single injection of platelet-rich plasma (PRP) for the treatment of refractory distal biceps tendonitis: long-term results of a prospective multicenter cohort study. Knee Surgery, Sports Traumatology, Arthroscopy. 2016;24(7):2308-2312.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Wesner M, Defreitas T, Bredy H, Pothier L, Qin Z, McKillop B, Gross DP. A pilot study evaluating the effectiveness of platelet-rich plasma therapy for treating degenerative tendinopathies: a randomized control trial with synchronous observational cohor // PLOSone. 2016. Vol.11, №2. P. e0147842. DOI:10.1371/journal.pone.0147842.</mixed-citation><mixed-citation xml:lang="en">Wesner M, Defreitas T, Bredy H, Pothier L, Qin Z, McKillop B, Gross DP. A pilot study evaluating the effectiveness of plateletrich plasma therapy for treating degenerative tendinopathies: a randomized control trial with synchronous observational cohor. PLOSone. 2016;11(2):e0147842.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Башкина А.С., Широкова Л.Ю., Князева Т.С., Паруля О.М., Абросимова Е.Б., Носков С.М. Применение обогащенной тромбоцитами плазмы в купировании болевого синдрома большого вертела // Травматология и ортопедия России. 2011. №2 (60). С. 57-61.</mixed-citation><mixed-citation xml:lang="en">Bashkina AS, Shirokova LYu, Khyazeva TS, Parulya OM, Abrosimova EV, Naskov SM. Application of platelet-rich plasma in reduction of greater trochanteric pain syndrome. Traumatology and Orthopedics of Russia. 2011;2(60):57-61. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Baltzer AWA, Moser C, Jansen SA, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment of knee osteoarthritis // Osteoarthritis and Cartilage. 2009. Vol.17. P. 152-160.</mixed-citation><mixed-citation xml:lang="en">Baltzer AWA, Moser C, Jansen SA, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment of knee osteoarthritis. Osteoarthritis and Cartilage. 2009;17:152-160.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Николаев В.И., Чернякова Ю.М., Пинчук Л.С., Линкевич Е.Р., Белоенко Е.Д. Локальная терапия гонартроза аутосывороткой крови пациента // Известия НАН Беларуси, серия медицинских наук. 2006. №4. С.50-53.</mixed-citation><mixed-citation xml:lang="en">Nikolaev VI, Chernyakova YuM, Pinchuk LS, Linkevich ER, Beloenko ED. Lokalnaya terapiya gonartroza autosyvorotkoy krovi patsiyenta. Proceedings of the National Academy of Sciences of Belarus. Medical Series. 2006;4:50-53. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Filardo G, Kon E, Buda R, Timoncini A, Di Martino A, Cenaсchi A, Fornasari PM, Giannini S, Marcacci M. Plateletrich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis // Knee Surgery, Sports Traumatology, Arthroscopy. 2011. Vol.19. P. 528-535.</mixed-citation><mixed-citation xml:lang="en">Filardo G, Kon E, Buda R, Timoncini A, Di Martino A, Cenaсchi A, Fornasari PM, Giannini S, Marcacci M. Plateletrich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy. 2011;19:528-535.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Мастыков А.Н., Дейкало В.П., Болобошко К.Б. Обогащенная тромбоцитами плазма в лечении постравматической хондропатии коленного сустава // Новости хирургии. 2012. T.20, №5. С. 77-81.</mixed-citation><mixed-citation xml:lang="en">Mastykau AN, Deykalo VP, Balaboshka KB. Obogashchennaya trombotsitami plazma v lechenii postravmaticheskoy khondropatii kolennogo sustava. Novosti khirurgii. 2012; 20(5):77- 81. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Широкова Л.Ю., Носков С.М., Бахтиарова Т.И., Снигирева А.В., Носкова Т.С. Локальная терапия гонартрозааутологичной, обогащенной тромбоцитами плазмы // Современные технологии в медицине. 2012. №1. С.97-100.</mixed-citation><mixed-citation xml:lang="en">Shirokova LYu, Noskov SM, Bakhtiarova TI, Shigiryova AV, Noskova TS. Lokalnaya terapiya gonartroza autologichnoy obogashchennoy trombotsitami plazmy. Modern Technologies in Medicine. 2012;(1):97-100. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Su K, Bai Y, Wang J, Zhang H, Liu H, Ma S. Comparison of hyaluronic acid and PRP intra-articular injection with combined intra-articular and intraosseous injections to treat patients with knee osteoarthritis // Clinical Rheumatology. 2018. Vol.37, №5. P. 1341-1350.</mixed-citation><mixed-citation xml:lang="en">Su K, Bai Y, Wang J, Zhang H, Liu H, Ma S. Comparison of hyaluronic acid and PRP intra-articular injection with combined intra-articular and intraosseous injections to treat patients with knee osteoarthritis. Clinical Rheumatology. 2018;37(5): 1341-1350.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Glynn LG, Mustafa A, Casey M, Krawczyk J, Bloom J, Galvin R, Hannigan A, Dunne CP, Murphy AW, Mallen C. Platelet-rich plasma (PRP) therapy for knee arthritis: a feasibility study in primary care // Pilot and Feasibility Studies. 2019. Vol.4. P. 93.</mixed-citation><mixed-citation xml:lang="en">Glynn LG, Mustafa A, Casey M, Krawczyk J, Bloom J, Galvin R, Hannigan A, Dunne CP, Murphy AW, Mallen C. Platelet-rich plasma (PRP) therapy for knee arthritis: a feasibility study in primary care. Pilot and Feasibility Studies. 2019;4:93.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Lin K-Y, Yang C-C, Hsu C-J, Yeh M-L, Renn J-K. Intraarticular injection of platelet-rich plasma is superior to hyaluronic acid or saline solution in the treatment of mild to moderate knee osteoarthritis: a randomized, double-blind, triple-parallel, placebocontrolled clinical trial // Arthroscopy: The Journal of Arthroscopic and Related Surgery. 2019. Vol.35, №1. P. 106-117.</mixed-citation><mixed-citation xml:lang="en">Lin KY, Yang CC, Hsu CJ, Yeh ML, Renn JK. Intraarticular injection of platelet-rich plasma is superior to hyaluronic acid or saline solution in the treatment of mild to moderate knee osteoarthritis: a randomized, double-blind, triple-parallel, placebocontrolled clinical trial. Arthroscopy: The Journal of Arthroscopic and Related Surgery. 2019;35(1):106-117.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Guillibert C, Charpin C, Raffray M, Benmenni A, Dehaut F-X, El Ghobeira G, Giogi R, Magalon J, Arniaud D. Single injection of high volume of autologous pure PRP provides a significant improvement in knee osteoarthritis: a prospective routine care study // International Journal of Molecular Science. 2019. Vol.20. P. 1327.</mixed-citation><mixed-citation xml:lang="en">Guillibert C, Charpin C, Raffray M, Benmenni A, Dehaut F-X, El Ghobeira G, Giogi R, Magalon J, Arniaud D. Single injection of high volume of autologous pure PRP provides a significant improvement in knee osteoarthritis: a prospective routine care study. International Journal of Molecular Science. 2019;20:1327.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Bottegoni C, Dei Giudici L, Salvemini S, Chiurazzi E, Bencivenga R, Gigante A. Homologous platelet-rich plasma for the treatment of knee osteoarthritis in selected elderly patients: an open-label, uncontrolled, pilot study // Therapeutic Advances in Musculoskeletal Disease. 2016. Vol.8, №2. P. 35-41.</mixed-citation><mixed-citation xml:lang="en">Bottegoni C, Dei Giudici L, Salvemini S, Chiurazzi E, Bencivenga R, Gigante A. Homologous platelet-rich plasma for the treatment of knee osteoarthritis in selected elderly patients: an open-label, uncontrolled, pilot study. Therapeutic Advances in Musculoskeletal Disease. 2016;8(2):35-41.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
